Australia is closely awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://sahilfyii643736.blgwiki.com/2533554/retatrutide_australia_a_potential_breakthrough_for_losing_weight